Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online:451
  • Home
  • Print this page
  • Email this page
Year : 2020  |  Volume : 34  |  Issue : 1  |  Page : 3-7

Central sensitization and its role in chronic pain: What can ketamine do?

Department of Anesthesia, Emory University, Atlanta, GA, USA

Correspondence Address:
Dr. Vinita Singh
1364 Clifton Rd, Emory University Hospital, Atlanta, 30322, GA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijpn.ijpn_25_20

Rights and Permissions

Central sensitization plays a crucial role in the development of chronic pain. NMDA receptors play a key role in central sensitization. Ketamine, an NMDA receptor antagonist, can help in refractory chronic pain. Although intravenous is the most common route utilized for delivery of ketamine, other routes such as oral, subcutaneous, topical and intranasal, have been explored. Here we review key research articles regarding the use of ketamine for chronic pain.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded394    
    Comments [Add]    

Recommend this journal